FindTrial
Sign In

Comparison of effects of two dosage of Aspirin (3-5 mg/kg/d and 30-50 mg/kg/d) in acute phase (febrile phase) of Kawasaki disease on the coronary artery aneurysm (dilation of arteries of heart).

Low dose (3-5 mg/kg/d) vs moderate dose (30-50 mg/kg/d) aspirin in acute phase of kawasaki disease. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/102784
Enrollment
398
Registered
2026-02-02
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M303- Mucocutaneous lymph node syndrome[Kawasaki]

Interventions

Intervention1: Low dose aspirin: 3-5 mg/kg/d aspirin in acute phase of Kawasaki Disease (till the patient is afebrile for 48 hours) Control Intervention1: Moderate dose aspirin: 30-50 mg/kg/d aspirin

Sponsors

Burdwan Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients suffering from Kawasaki Disease and presented the Emeregency or Out-patient.

Exclusion criteria

Exclusion criteria: Known cardiac anomaly, Refusal of consent, Left against medical advice

Design outcomes

Primary

MeasureTime frame
Coronary artery aneurysmTimepoint: At the time of entry in study, at discharge and at 8 weeks after discharge.—

Secondary

MeasureTime frame
Adverse effects of aspirin, Duration of fever & hospitalisation, IVIG resistanceTimepoint: At the time of discharge from hospital—

Countries

India

Contacts

Public ContactKamirul Islam

Burdwan Medical College

drarchan84@gmail.com9051983804

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026